Lars Steinstraesser

researcher

Lars Steinstraesser is …
instance of (P31):
humanQ5

P735given nameLarsQ15635262
LarsQ15635262
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q43197715A human full-skin culture system for interventional studies.
Q40746569A novel human skin chamber model to study wound infection ex vivo
Q45862111A novel titanium wound chamber for the study of wound infections in pigs.
Q53809169A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice.
Q51737373Accelerated angiogenic induction and vascular integration in a novel synthetic scaffolding matrix for tissue replacement.
Q34108244Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns
Q36761588Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases
Q39866579Antiseptics in surgery
Q41941685Biphasic synovial sarcoma of the extremity: quadruple approach of isolated limb perfusion, surgical ablation, adipofascial perforator flap and radiation to avoid amputation
Q51654253Bronchoscopy screening in primary oral squamous cell carcinoma: a 10-year experience.
Q24814363Burn wounds infected with Pseudomonas aeruginosa triggers weight loss in rats
Q34984001Burn-induced organ dysfunction: vagus nerve stimulation attenuates organ and serum cytokine levels
Q41334331Burn-induced organ dysfunction: vagus nerve stimulation improves cardiac function
Q33249097Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues
Q47666969Cryopreserved human amniotic membrane for soft tissue repair in rats
Q37756018Diagnosis and management of primary breast sarcoma
Q39867194Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity
Q35633737Elastofibroma dorsi--differential diagnosis in chest wall tumours
Q37256217Electrotransfer parameters as a tool for controlled and targeted gene expression in skin
Q33321948Enhanced susceptibility to infections in a diabetic wound healing model
Q33289550Epiploic appendagitis--clinical characteristics of an uncommon surgical diagnosis
Q57184714Establishing efficient xenograft models with intrinsic vascularisation for growing primary human low-grade sarcomas
Q39562979Establishment of a synovial sarcoma model in athymic nude mice
Q33804879Evaluation of human amniotic membrane as a wound dressing for split-thickness skin-graft donor sites.
Q33799990Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery.
Q39804558Evaluation of toxic side effects of clinically used skin antiseptics in vitro.
Q40191396Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma
Q53158425Experimental murine model of primary high grade undifferentiated pleomorphic sarcoma not otherwise specified.
Q51819406Expression profile of human beta-defensin 3 in oral squamous cell carcinoma.
Q24796008Feasibility of chemosensitivity testing in soft tissue sarcomas
Q80993795Fournier's gangrene after Milligan-Morgan hemorrhoidectomy requiring subsequent abdominoperineal resection of the rectum: report of a case
Q39608984Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
Q39488599Genotoxic and cytotoxic activity of host defense peptides against human soft tissue sarcoma in an in vitro model
Q39174805Growth rate of late passage sarcoma cells is independent of epigenetic events but dependent on the amount of chromosomal aberrations
Q37108625Host defense peptides and the new line of defence against multiresistant infections
Q37786712Host defense peptides and their antimicrobial-immunomodulatory duality
Q35010044Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?
Q37127271Host defense peptides in wound healing.
Q34167884Induction of angiogenesis and neovascularization in adjacent tissue of plasma-collagen-coated silicone implants
Q24803217Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
Q34373912Innate defense regulator peptide 1018 in wound healing and wound infection
Q41453719Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5.
Q64931252Intravital monitoring of microcirculatory and angiogenic response to lactocapromer terpolymer matrix in a wound model.
Q33532226Laser-mediated fixation of collagen-based scaffolds to dermal wounds.
Q30157383Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Q55451307Malignant fibrous histiocytoma—pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study.
Q33818284Microsurgical reconstruction of the oral cavity with free flaps from the anterolateral thigh and the radial forearm: a comparison of perioperative data from 161 cases.
Q40135060Nucleofection: a new method for cutaneous gene transfer?
Q38928882Numerical and structural chromosomal anomalies in undifferentiated pleomorphic sarcoma
Q35600198Oncolytic activities of host defense peptides
Q33670905Oncolytic designer host defense peptide suppresses growth of human liposarcoma
Q41813290Papillon-Lefèvre syndrome and squamous cell carcinoma: a case report
Q53088990Pressure garment therapy alone and in combination with silicone for the prevention of hypertrophic scarring: randomized controlled trial with intraindividual comparison.
Q37110014Proximal major limb amputations--a retrospective analysis of 45 oncological cases
Q44457507Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features
Q40120614Repair of oronasal fistulae by interposition of multilayered amniotic membrane allograft.
Q47706495Repair of oronasal fistulas with human amniotic membrane in minipigs
Q24810525Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways
Q45926277Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma--value of endoscopic screening: 10-year experience.
Q37037135Role of host defense peptides of the innate immune response in sepsis
Q37696015Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing
Q33869797Suppression of soft tissue sarcoma growth by a host defense-like lytic peptide
Q39905680TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.
Q45352256The Vascularised Groin Chamber: A Novel Model for Growing Primary Human Liposarcoma in Nude Mice
Q45003781The effectiveness of pedicled groin flaps in the treatment of hand defects: results of 49 patients
Q33375369The role of allogenic amniotic membrane in burn treatment

Search more.